Finzati - Logo
PDEX logo

Pro-Dex, Inc.

PDEXMedical - Instruments & Supplies
Strong market move
PDEX+18.88%
vs. previous close $61.75
$73.41
+11.66 (+18.88%)
Current price
EarningsSep 4, 11:09 AM UTC
New financial eventQ4 2026Positive

Pro-Dex, Inc. has reported Q4 2026 financial results

The latest report is predominantly positive and shows an overall improvement in financial performance. Revenue and profitability advanced at a meaningful pace, while the weaker areas should be reviewed in context. The report may attract increased investor attention and price volatility.

Finzati signal
Positive development
Sep 4, 11:09 AM UTC
Improved
+16.63%
Revenue
Improved
+138.88%
Net income
Changed
-65.79%
Free cash flow
Improved
+14.43%
Cash
Changed
+17.57%
Total debt
What changed
Revenue increased 16.6% versus the comparable prior period, indicating stronger top-line growth.
Net income increased 138.9%, showing improved profitability.
Free cash flow declined 65.8%, indicating pressure on cash generation.
Total debt increased 17.6%, which may reduce financial flexibility.
Based on newly processed financial statements and comparable prior-period data.This is informational analysis, not investment advice.
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Sep 4, 2026, 11:09 AM UTCLast profile update: Sep 4, 2026, 12:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$73.41
Change18.88%
Shares Out3.32M
Market Cap$243.51M
Enterprise Value$253.41M
52W Range23.47 - 69.86
Beta0.05
P/E17.82
P/S3.14
P/B5.11
P/FCF34.42
EV/Sales3.27

Investment DNA

How strong this company looks for long-term investors

80
out of 100
Business Quality
Margins, moat, returns
83/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
72/100
Why this score
Stable or improving margins · 17.6%Positive revenue growth · 20.1%Positive free cash flow · 2.24Reasonable earnings multiple · 13.81Manageable debt level · 0.38Healthy liquidity · 4.1

Analyst view

Analyst sentiment and price target

PDEX
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0

Company Overview

IPO: 8/7/1986
Industry: Medical - Instruments & Supplies
P/B i: 5.11
Debt / Equity i: 0.38
Operating Margin: 16.75%
Net Margin: 17.62%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.38
Current Ratio: 4.10
Quick Ratio: 2.45
Status: Good

Insider Transactions

Recent executive and insider activity

Domingo Angelita Rebamontan
Transaction: 07/23/2026
BUY
Change
+19
Price
$33.25
Filing
07/24/2026
Type
BUY
Domingo Angelita Rebamontan
Transaction: 03/16/2026
SELL
Change
-998
Price
$47.24
Filing
07/14/2026
Type
SELL
Van Kirk Richard Lee Jr
Transaction: 07/01/2026
SELL
Change
-5,279
Price
$62.74
Filing
07/06/2026
Type
SELL